Abstract Tobacco use through cigarette smoking is the leading preventable cause of death in the developed world. Nicotine, a psychoactive component of tobacco, appears to play a major role in tobacco dependence, but the reinforcing effects of nicotine have often been difficult to demonstrate directly in controlled studies with laboratory animals or human subjects. Here we update our earlier review published in Psychopharmacology (Berl) in 2006 on findings obtained with various procedures developed to study dependence-related behavioral effects of nicotine in experimental animals and humans. Results obtained with drug self-administration, conditioned place preference, subjective reports of nicotine effects and nicotine discrimination indicate that nicotine can function as an effective reinforcer of drug-seeking and drug-taking behavior both in experimental animals and humans under appropriate conditions. Interruption of chronic nicotine exposure produces ratings of drug withdrawal and withdrawal symptoms that may contribute to relapse. Difficulties encountered in demonstrating reinforcing effects of nicotine under some conditions, relative to other drugs of abuse, may be due to weaker primary reinforcing effects of nicotine, to aversive effects produced by nicotine, or to a more critical contribution of environmental stimuli to the maintenance of drug-seeking and drug-taking behavior with nicotine than with other drugs of abuse. Several recent reports suggest that other chemical substances inhaled along with nicotine in tobacco smoke may play a role in sustaining smoking behavior. However, conflicting results have been obtained with mice and rats and these findings have not yet been validated in nonhuman primates or human subjects. Taken together, these findings suggest that nicotine acts as a typical drug of abuse in experimental animals and humans in appropriate situations.
Introduction
Tobacco smoking is presently estimated to cause 20% of all deaths in developed countries. As with other types of drug dependence, tobacco dependence is described as a chronic, relapsing disorder in which compulsive drug-seeking and drugtaking behavior persist despite negative consequences and the motivation to quit. The highly addictive effects of tobacco are exemplified by the great difficulty in quitting smoking. Although most smokers want to stop, only a small percent succeed. It is now becoming clear that continued tobacco use induces adaptive changes in the central nervous system that lead to drug dependence (American Psychiatric Association 2000). Nicotine, the major psychoactive component of tobacco, is thought to play a critical role in tobacco dependence through its actions as a reinforcer of drug-seeking and drug-taking behavior (Fiore et al. 2000; Henningfield and Goldberg 1983a, b; Stolerman and Shoaib 1991) . Nevertheless, tobacco smoke contains several hundred other chemical substances, some of which have psychoactive effects or may enhance the psychoactive effects of nicotine, and these other substances may contribute to the reinforcing effects of tobacco smoking (Fowler et al. 1996a, b) . Indeed, the reinforcing effects of nicotine have often been difficult to demonstrate directly in past controlled studies with either laboratory animals or humans as experimental subjects. As a result, there has been some controversy in the literature about the validity of previous findings that nicotine can produce reinforcing effects in experimental animals or human subjects (Dar and Frenk 2002, 2004; Robinson and Pritchard 1992) .
A variety of laboratory animal models are available to study the cardinal features of drug dependence (Deroche-Gamonet et al. 2004; Everitt and Robbins 2000; Goldberg et al. 1975; Goldberg et al. 1981a Goldberg et al. , b, 1975 Goldberg et al. , 1979 Katz and Goldberg 1988; Le Foll and Goldberg 2005a-d; Markou et al. 1993; Schindler et al. 2002; Schuster and Woods 1968; Spealman and Goldberg 1978; Vanderschuren and Everitt 2004) . The effects of nicotine have been evaluated using animal models for studying the
